Formulation and Drug Delivery

Zika Vaccine Clinical Trial Begins

August 20, 2018

The National Institute of Allergy and Infectious Diseases began a first-in-human trial of an experimental live, attenuated Zika virus vaccine.

Catalent Acquires Juniper Pharmaceuticals

August 20, 2018

The acquisition of Juniper expands and strengthens Catalent’s offerings in formulation development, bioavailability solutions, and clinical-scale oral dose manufacturing.

First Generic Version of EpiPen Gets Approval

August 17, 2018

FDA approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector.

Emergent to Acquire Specialty Vaccines Company PaxVax

August 17, 2018

The acquisition is expected to support Emergent BioSolutions’ focus on public health threats and emerging infectious disease.

Leaf Expression Systems’ Facility Begins Operations

August 17, 2018

The company’s purpose-built facility in Norwich, United Kingdom specializes in plant-based expression of proteins, metabolites, and complex natural products.

Pfizer, BioNTech to Develop mRNA-based Flu Vaccines

August 16, 2018

Pharmaceutical Technology's In the Lab eNewsletter

The companies entered a multi-year R&D collaboration to develop mRNA-based flu vaccines.